In vitro kinetics of factor VIII activity in patients with mild haemophilia A and a discrepancy between one‐stage and two‐stage factor VIII assay results

• Published in: British journal of haematology 2007-01, Vol.136 (1), p.138-145
• Main Authors: Rodgers, Susan E., Duncan, Elizabeth M., Barbulescu, Denise M., Quinn, Diana M., Lloyd, John V.
• Format: Article
• Language: English
• Subjects: Biological and medical sciences; Blood Coagulation Tests; Chromogenic Compounds - pharmacology; chromogenic factor VIII; discrepant mild haemophilia; factor VIII; Factor VIII - genetics; Factor VIII - pharmacokinetics; Hematologic and hematopoietic diseases; Hemophilia A - blood; Hemophilia A - genetics; Humans; Medical sciences; Mutation; Platelet diseases and coagulopathies; Predictive Value of Tests; Thromboplastin - metabolism; Time Factors; two‐stage factor VIII assay
• ISSN: 0007-1048; 1365-2141
• DOI: 10.1111/j.1365-2141.2006.06402.x

Summary In some mild haemophilia A patients (discrepant haemophilia), factor VIII coagulant activity (FVIII:C) levels, by one‐stage assay are more than double than those by two‐stage assay. This may be due to the longer incubation times (10–12 min) in the two‐stage assay. This study aimed to determine the time course of the activation phase of the two‐stage assay, using both classical coagulation and chromogenic detection methods. In both systems, for equivalent patients (equivalent FVIII:C levels by one‐stage and two‐stage assays, n = 6, all different mutations), similar FVIII:C results were obtained with short‐ or long‐incubation times. In contrast, plasma from discrepant patients (n = 8, five different mutations) showed higher FVIII:C at shorter incubation times than after longer incubation times. In the chromogenic assay, FVIII:C levels were higher after incubation for 2 min (23–56%, mean 41%) than after 10 min (19–41%, mean 29%). In the classical coagulation assay, FVIII:C levels were higher at shorter incubation times (21–64%, mean 37%) than with the longer incubation times usually used (13–29%, mean 23%). These time‐course experiments have verified that the longer incubation time used in the two‐stage assay is at least partly responsible for the lower FVIII:C measured by that assay in discrepant haemophilia.